182 related articles for article (PubMed ID: 26700202)
1. Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study.
Noda S; Onoda N; Asano Y; Kurata K; Tokumoto M; Morisaki T; Kashiwagi S; Takashima T; Hirakawa K
Int J Surg; 2016 Feb; 26():1-5. PubMed ID: 26700202
[TBL] [Abstract][Full Text] [Related]
2. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
Majid S; Rydén L; Manjer J
BMC Cancer; 2019 Jun; 19(1):626. PubMed ID: 31238899
[TBL] [Abstract][Full Text] [Related]
3. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
4. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
5. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
[TBL] [Abstract][Full Text] [Related]
6. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.
Guenther JM; Hansen NM; DiFronzo LA; Giuliano AE; Collins JC; Grube BL; O'Connell TX
Arch Surg; 2003 Jan; 138(1):52-6. PubMed ID: 12511150
[TBL] [Abstract][Full Text] [Related]
7. T-stage and positive sentinel nodes ratio are the useful factors to predict non-sentinel node metastasis in breast cancer patients with macro-metastasis in the sentinel node.
Noda S; Onoda N; Asano Y; Kurata K; Kashiwagi S; Kawajiri H; Takashima T; Hirakawa K
Int J Surg; 2015 Feb; 14():56-60. PubMed ID: 25597234
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
[TBL] [Abstract][Full Text] [Related]
11. Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Breast Cancer Res Treat; 2019 Jun; 175(3):713-719. PubMed ID: 30877405
[TBL] [Abstract][Full Text] [Related]
12. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
13. [The importance of the extracapsular extension of the sentinel node metastasis in the surgical treatment of breast cancer].
Maráz R; Venczel L; Sikorszki L; Ambrózay É; Serfőző O; Rajtár M; Cserni G
Magy Seb; 2020 Mar; 73(1):16-22. PubMed ID: 32172574
[TBL] [Abstract][Full Text] [Related]
14. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
Majid S; Rydén L; Manjer J
World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
[TBL] [Abstract][Full Text] [Related]
16. Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population.
Dingemans SA; de Rooij PD; van der Vuurst de Vries RM; Budel LM; Contant CM; van der Pool AE
Ann Surg Oncol; 2016 Feb; 23(2):477-81. PubMed ID: 26369528
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes.
Schrenk P; Tausch C; Wölfl S; Bogner S; Fridrik M; Wayand W
Am J Surg; 2008 Aug; 196(2):176-83. PubMed ID: 18513692
[TBL] [Abstract][Full Text] [Related]
18. ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.
Li JW; Mo M; Yu KD; Chen CM; Hu Z; Hou YF; Di GH; Wu J; Shen ZZ; Shao ZM; Liu GY
PLoS One; 2014; 9(12):e114646. PubMed ID: 25504233
[TBL] [Abstract][Full Text] [Related]
19. Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.
Bonsang-Kitzis H; Mouttet-Boizat D; Guillot E; Feron JG; Fourchotte V; Alran S; Pierga JY; Cottu P; Lerebours F; Stevens D; Vincent-Salomon A; Sigal-Zafrani B; Campana F; Rouzier R; Reyal F
PLoS One; 2017; 12(2):e0169962. PubMed ID: 28241044
[TBL] [Abstract][Full Text] [Related]
20. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
